Björn Lennart Dahlöf
Fortune : 833 067 $ au 31/05/2026
Fortune : 833 067 $ au 31/05/2026
Björn Lennart Dahlöf is currently Director at Scandinavian Cri AB, BD Medical Consulting AB, Brazilinvest AB, Tandaxessen i Sverige, Pexa AB (since 2021), Goldwater Sweden AB, and Cereno Scientific AB (Chief Scientific Officer since 2022).
Holds the position of Deputy Director at J N K Clothing Co. AB. Works as Researcher at the University of Gothenburg, Senior Physician at Ostra Sjukhuset, and Associate Professor at Sahlgrenska University.
Formerly Director at A+ Science Holding AB, Vicore Pharma AB, A+ Science AB, Vicore Pharma Holding AB, and Scandinavian CRI Holding AB.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2024 | 1 439 076 ( 0,46 % ) | 833 067 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CERENO SCIENTIFIC AB | Directeur Technique/Scientifique/R&D | 01/09/2018 |
| PEXA AB | Directeur/Membre du Conseil | 01/01/2021 |
Ostra Sjukhuset | Corporate Officer/Principal | - |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Brazilinvest AB | Directeur/Membre du Conseil | - |
Scandinavian Cri AB | Directeur/Membre du Conseil | - |
Tandaxessen i Sverige | Directeur/Membre du Conseil | - |
Goldwater Sweden AB | Directeur/Membre du Conseil | - |
BD Medical Consulting AB | Directeur/Membre du Conseil | - |
| ░ ░ ░ ░░░░░░░░ ░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░░░ ░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░ ░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 16 |
|---|---|
A+ Science Holding AB
A+ Science Holding AB MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
A+ Science AB
A+ Science AB Miscellaneous Commercial ServicesCommercial Services Plans and conducts clinical trials for pharmaceutical and medical device companies | Commercial Services |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scandinavian Cri AB | |
Vicore Pharma Holding AB
Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
Ostra Sjukhuset | |
BD Medical Consulting AB | |
Brazilinvest AB | |
Scandinavian CRI Holding AB | |
Tandaxessen i Sverige | |
Pexa AB
Pexa AB Medical SpecialtiesHealth Technology Provides collection of trace elements and potential biomarkers for specific lung deceases | Health Technology |
Cereno Scientific AB
Cereno Scientific AB Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Goldwater Sweden AB | |
J N K Clothing Co. AB | |
Sahlgrenska University
Sahlgrenska University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national